Oxytocin to Decrease Blood Loss During Cesarean Section

• Status: Completed
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

The goal of this study is to determine the best dose of a drug called oxytocin, that is usually used to stop bleeding during a delivery, when used during a cesarean delivery. It will be administered during cesarean section in order to decrease the amount blood loss. The investigators are proposing to have 3 groups of subjects each given a different safe dose of oxytocin and then to assess the effectiveness of each regimens on the amount blood lost during cesarean sections.This will let use know which is the best lowest dose needed.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: American University of Beirut Medical Center
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• Study subjects will be women delivering via an elective cesarean section at term

• All study subjects will have singleton gestation with no obstetric or medical complication.

Exclusion Criteria:

• Laboring women

• Multifetal gestation

• Prolonged oxytocin use (>12 hours)

• Hypertensive disorders

• Chorioamnionitis

• Suspected macrosomia

• Polyhydramnios

• History of postpartum Hemorrhage

• Clotting disorder

• Intake of magnesium sulfate

• Uterine fibroids

• Placenta previa

• Placental abruption

• Anticoagulation